rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

GRI Bio, Inc.

GRI · Nasdaq

Health CareBiotechnologyNot moving yet

GRI stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 45 weeks. It is 31.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 45
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
10 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders10+4 on the quarter
New · exited5 · 1
Reported value$115K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 202621,368$38K+21,368
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202613,869$25K-4,569−24.8%
CITADEL ADVISORS LLCnew · filed 14 Aug 202613,376$24K+13,376
MORGAN STANLEYnew · filed 13 Aug 20268,737$15K+8,737
UBS Group AGreduced · filed 13 Aug 20264,920$8,708-3,802−43.6%
Tower Research Capital LLC (TRC)added · filed 11 Aug 20262,434$4,308+1,374+129.6%
BARCLAYS PLCnew · filed 14 Aug 202683$147+83
BlackRock, Inc.unchanged · filed 7 Aug 20267$1200.0%
DANSKE BANK A/Sunchanged · filed 10 Aug 20262$400.0%
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 20262$4+2
31 Mar 2025 – 30 Jun 2026
5810Mar 25Jun 25Dec 25Mar 26Jun 26

Everyone who traded it

Camilla Simpson V Company insiderDirector · last 18 Sep 20250 · 0
David Charles Baker Company insiderDirector · last 18 Sep 20251 · 0
David Leslie Szekeres Company insiderDirector · last 18 Sep 20250 · 0
Leanne Kelly Company insiderChief Financial Officer · last 18 Sep 20253 · 0
Roelof Rongen Company insiderDirector · last 18 Sep 20250 · 0
Vipin Chaturvedi Company insiderChief Scientific Officer · last 18 Sep 20250 · 0
Walter Marc Hertz Company insiderChief Executive Officer · last 18 Sep 20250 · 0
Albert Agro Company insiderChief Medical Officer · last 21 Apr 20230 · 0
Marella Thorell Company insiderDirector · last 13 Dec 20220 · 0
Joseph E. Payne Company insiderDirector · last 9 Jun 20222 · 0
Richard Ammer Company insiderDirector · last 9 Jun 20220 · 0
Meenu Chhabra Company insiderDirector · last 23 Feb 20220 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-199%
Share count trendFY 2025 · to 29 Jan 2026190%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.2M
Free cash flowFY 2025 · to 31 Dec 2025−$10.2M

Analyst forecasts

No analyst forecasts yet.